HCA Healthcare, Inc. $HCA Stock Position Boosted by Stance Capital LLC

Key Points

• Stance Capital LLC increased its holdings in HCA Healthcare, Inc. by 2,419.1% in the first quarter, now owning 14,359 shares valued at approximately $4.96 million.
• HCA Healthcare reported $6.84 earnings per share for the last quarter, surpassing consensus estimates, and set its FY 2025 guidance between 25.500-27.000 EPS.
• The company declared a quarterly dividend of $0.72 per share, with a yield of 0.7%, to be paid out on September 30th.

Stance Capital LLC lifted its position in shares of HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 2,419.1% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 14,359 shares of the company's stock after purchasing an additional 13,789 shares during the period. HCA Healthcare comprises approximately 3.5% of Stance Capital LLC's portfolio, making the stock its 3rd largest position. Stance Capital LLC's holdings in HCA Healthcare were worth $4,962,000 at the end of the most recent quarter.

A number of other hedge funds have also recently modified their holdings of HCA. Cheviot Value Management LLC purchased a new position in shares of HCA Healthcare in the 1st quarter valued at $26,000. Saudi Central Bank purchased a new stake in HCA Healthcare in the first quarter valued at approximately $26,000. WPG Advisers LLC purchased a new stake in HCA Healthcare in the first quarter valued at approximately $27,000. Atwood & Palmer Inc. purchased a new stake in HCA Healthcare in the first quarter valued at approximately $28,000. Finally, Bartlett & CO. Wealth Management LLC lifted its stake in HCA Healthcare by 888.9% in the first quarter. Bartlett & CO. Wealth Management LLC now owns 89 shares of the company's stock valued at $31,000 after buying an additional 80 shares during the last quarter. 62.73% of the stock is owned by hedge funds and other institutional investors.

HCA Healthcare Price Performance

HCA traded down $19.40 during trading on Wednesday, reaching $394.00. 2,013,997 shares of the stock were exchanged, compared to its average volume of 1,538,078. The business's 50 day moving average price is $381.31 and its two-hundred day moving average price is $361.47. The company has a debt-to-equity ratio of 69.07, a current ratio of 0.98 and a quick ratio of 0.86. The company has a market capitalization of $92.19 billion, a price-to-earnings ratio of 16.56, a P/E/G ratio of 1.31 and a beta of 1.41. HCA Healthcare, Inc. has a 1 year low of $289.98 and a 1 year high of $420.98.

HCA Healthcare (NYSE:HCA - Get Free Report) last posted its earnings results on Friday, July 25th. The company reported $6.84 EPS for the quarter, topping analysts' consensus estimates of $6.20 by $0.64. The company had revenue of $18.61 billion for the quarter, compared to the consensus estimate of $18.49 billion. HCA Healthcare had a negative return on equity of 7,363.11% and a net margin of 8.21%.HCA Healthcare's quarterly revenue was up 6.4% compared to the same quarter last year. During the same period in the previous year, the business earned $5.50 earnings per share. HCA Healthcare has set its FY 2025 guidance at 25.500-27.000 EPS. As a group, equities research analysts anticipate that HCA Healthcare, Inc. will post 24.98 earnings per share for the current year.

HCA Healthcare Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 30th. Stockholders of record on Tuesday, September 16th will be given a $0.72 dividend. This represents a $2.88 annualized dividend and a dividend yield of 0.7%. The ex-dividend date is Tuesday, September 16th. HCA Healthcare's dividend payout ratio is currently 12.11%.

Insider Activity

In other news, EVP Michael S. Cuffe sold 3,836 shares of the company's stock in a transaction on Monday, September 8th. The stock was sold at an average price of $418.84, for a total value of $1,606,670.24. Following the sale, the executive vice president directly owned 31,503 shares in the company, valued at $13,194,716.52. This represents a 10.85% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. 1.30% of the stock is owned by corporate insiders.

Wall Street Analyst Weigh In

A number of brokerages have weighed in on HCA. Wolfe Research cut HCA Healthcare from an "outperform" rating to a "peer perform" rating in a research note on Monday, July 28th. Wall Street Zen raised HCA Healthcare from a "hold" rating to a "buy" rating in a report on Saturday, July 5th. Bank of America boosted their target price on HCA Healthcare from $375.00 to $410.00 and gave the company a "neutral" rating in a report on Wednesday. Royal Bank Of Canada dropped their target price on HCA Healthcare from $404.00 to $401.00 and set an "outperform" rating on the stock in a report on Monday, July 28th. Finally, Robert W. Baird upped their price objective on HCA Healthcare from $380.00 to $423.00 and gave the stock a "neutral" rating in a report on Thursday, August 14th. One investment analyst has rated the stock with a Strong Buy rating, seven have given a Buy rating and nine have issued a Hold rating to the stock. Based on data from MarketBeat, the company presently has an average rating of "Moderate Buy" and an average target price of $403.17.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.